HC Wainwright Issues Optimistic Estimate for MLTX Earnings
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Research analysts at HC Wainwright boosted their Q2 2025 EPS estimates for MoonLake Immunotherapeutics in a note issued to investors on Tuesday, May 27th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.76) for the quarter, up from their previous […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Research analysts at HC Wainwright boosted their Q2 2025 EPS estimates for MoonLake Immunotherapeutics in a note issued to investors on Tuesday, May 27th. HC Wainwright analyst R. Selvaraju now forecasts that the company will post earnings per share of ($0.76) for the quarter, up from their previous […]
